Related Experiment Video
Updated: Mar 20, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
Innate signaling by mycobacterial cell wall components and relevance for development of adjuvants for subunit
Hermann Giresse Tima1, Kris Huygen1, Marta Romano1
1a Immunology Service, Communicable and Infectious Diseases Department , Scientific Institute of Public Health (WIV-ISP) , Brussels , Belgium.
Introduction:
Pathogen recognition receptors (PRRs) recognize pathogen-associated molecular patterns, triggering the induction of inflammatory innate responses and contributing to the development of specific adaptive immune responses. Novel adjuvants have been developed based on agonists of PRRs. Areas covered: Lipid pathogen-associated molecular patterns (PAMPs) present in the cell wall of mycobacteria are revised, with emphasis on agonists of C-type lectin receptors, signaling pathways, and preclinical data supporting their use as novel adjuvants inducing cell-mediated immune responses. Their potential use as lipid antigens in novel tuberculosis subunit vaccines is also discussed. Expert commentary: Few adjuvants are licensed for human use and mainly favour antibody-mediated protective immunity. Use of lipid PAMPs that trigger cell-mediated immune responses could lead to the development of adjuvants for vaccines against intracellular pathogens and cancer.
Insights
Novel lipid adjuvants derived from mycobacteria activate C-type lectin receptors. These pathogen-associated molecular patterns show promise for vaccines targeting cell-mediated immunity against intracellular pathogens and cancer.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Pathogen recognition receptors (PRRs) are crucial for innate and adaptive immunity.
- Current adjuvants primarily induce antibody-mediated immunity, limiting options for intracellular pathogens.
- Novel adjuvants are needed to elicit cell-mediated immune responses.
Purpose of the Study:
- To review lipid pathogen-associated molecular patterns (PAMPs) from mycobacteria as novel vaccine adjuvants.
- To explore their potential in inducing cell-mediated immunity.
- To discuss their application in tuberculosis subunit vaccines and other diseases.
Main Methods:
- Review of literature on lipid PAMPs, PRRs, and C-type lectin receptors.
- Analysis of preclinical data on adjuvant efficacy.
- Discussion of signaling pathways involved.
Main Results:
- Lipid PAMPs from mycobacteria act as agonists for C-type lectin receptors.
- These PAMPs can induce potent cell-mediated immune responses.
- Preclinical data support their use as adjuvants.
Conclusions:
- Lipid PAMPs represent a promising class of novel adjuvants.
- They offer a strategy for developing vaccines against intracellular pathogens and cancer.
- Further research into their use in tuberculosis vaccines is warranted.
More Related Videos
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Regulation of Bacterial Virulence
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Vaccines
Microorganisms in Medicine and Therapeutics